Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
ConditionKnee Osteoarthrosis
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age42-75
SponsorUniversity of Jordan
About this trial
Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosis
Eligibility criteria
Qualifiers
Severe KOA stage III or IV by Laurance & Kellgren staging as judged by Posterioranterior (PA) Xray of the knee joint.
Willing to participate by signing the informed consent
Disqualifiers
Sublaxation beyond 20 degrees of the bones of the knee joint
Oral anticoagulants or heparin therapy
Heart failure or arrhythmia
Body Mass Index > 35
Trial design
Treatments tested in this trial
- Extracellular vesicles
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Jordan
Lead sponsor
Abdalla Awidi Abbadi, MD
Collaborator
The University of Jordan
Collaborator
Source ClinicalTrials.gov